Watch ICUI. Know when insiders buy.
One email the day a filing lands. Free.
Work order
38
FLAG · insiders 25, shorts 51
Insiders, 90 days
−$3.5M
net selling · 0 buys, 9 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $4.2BP/E 140.8DIV YIELD —FCF YIELD 3.65%REV TTM $2.2B −9.0%NET INCOME $30.1MNET CASH $133.8M52W 114.13 – 187.26SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $551.7M | +0.5% | 42.6% | $39.1M | $19.1M | −46.0% | 0.76 | $80.2M | $18.5M | $61.6M | Aug 6 |
| Q1 2026 · Mar 31 | $530.2M | −12.3% | 38.9% | $13.6M | $30.1M | — | 1.20 | $38.9M | $11.3M | $27.6M | Aug 6 |
| Q4 2025 · Dec 31derived | $540.7M | −14.1% | 37.5% | $5.6M | −$15.7M | — | -0.63 | $60.6M | $24.6M | $36M | Feb 19 |
| Q3 2025 · Sep 30 | $537M | −8.9% | 37.4% | $13.7M | −$3.4M | — | -0.14 | $56.7M | $29.1M | $27.6M | Nov 6 |
| Q2 2025 · Jun 30 | $548.9M | −8.0% | 37.9% | $10.6M | $35.3M | — | 1.43 | $11.2M | $19.7M | −$8.5M | Aug 6 |
| Q1 2025 · Mar 31 | $604.7M | +6.7% | 34.7% | $12.9M | −$15.5M | — | -0.63 | $51.3M | $14.6M | $36.7M | Aug 6 |
| Q4 2024 · Dec 31derived | $629.8M | +7.1% | 36.1% | $37.7M | −$23.8M | — | -0.98 | $40.2M | $24.1M | $16.1M | Feb 19 |
| Q3 2024 · Sep 30 | $589.1M | +6.5% | 34.8% | $8.2M | −$33M | −555.7% | -1.35 | $36.1M | $19.9M | $16.2M | Nov 6 |
| Q2 2024 · Jun 30 | $596.5M | — | 34.8% | $7.7M | −$21.4M | — | -0.88 | $82M | $19.5M | $62.5M | Nov 6 |
| Q1 2024 · Mar 31 | $566.7M | — | 32.7% | −$10.7M | −$39.5M | — | -1.63 | $45.8M | $15.9M | $29.9M | Nov 6 |
| Q4 2023 · Dec 31derived | $587.9M | — | 29.2% | −$12.2M | −$17.1M | — | -0.71 | $91.3M | $29.9M | $61.3M | Feb 19 |
| Q3 2023 · Sep 30 | $553.3M | — | 33.2% | $22.9M | $7.2M | — | 0.30 | $35.2M | $21.5M | $13.7M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.2B | 36.8% | $42.8M | $732K | 0.0% | 0.03 | $179.8M | $88M | $91.8M | $8.8M | — |
| FY2024 · to Dec 31 | $2.4B | 34.6% | $43M | −$117.7M | -4.9% | -4.83 | $204M | $79.4M | $124.7M | $12M | — |
| FY2023 · to Dec 31 | $2.3B | 32.8% | $22.8M | −$29.7M | -1.3% | -1.23 | $166.2M | $83.9M | $82.3M | $9.3M | — |
| FY2022 · to Dec 31 | $2.3B | 30.6% | −$42.9M | −$74.3M | -3.3% | -3.11 | −$62.1M | $90.3M | −$152.4M | $10.9M | — |
| FY2021 · to Dec 31 | $1.3B | 37.3% | $123.2M | $103.1M | 7.8% | 4.74 | $267.5M | $68.5M | $199M | $8.3M | — |
| FY2020 · to Dec 31 | $1.3B | 36.3% | $98.2M | $86.9M | 6.8% | 4.02 | $222.8M | $92M | $130.7M | $12.9M | — |
Every number comes from ICU MEDICAL INC/DE's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.